Monograph Details
|
|
Gastrointestinal Tract
> Hyperacidity, GERD, and ulcers
|
|
ZANTAC 150 |
| Manufacturer |
|
Boehringer Ingelheim Pharmaceuticals |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
H2 blocker. |
| Generic Name |
|
Ranitidine (as HCl) 150mg; tabs; sugar-free. |
| Also |
|
• ZANTAC 75
|
| Indications |
|
Relief or prevention of heartburn, acid indigestion, and sour stomach. |
| Children |
|
Not recommended. |
| Adults |
|
150mg once or twice daily. For prevention: take 30–60 minutes before problematic food/drinks. |
| Precautions |
|
Pregnancy (Cat.B). Nursing mothers. |
| How Supplied |
Tabs 75mg—4, 10, 20, 30, 60
150mg—24 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
